Evidence map›Paper›PMID 38638386›Full record

ReviewTanaffos2023

Light-Based Therapy: Novel Approach to Treat COVID-19.

Seyedeh Sara Azadeh, Gholamreza Esmaeeli Djavid, Sima Nobari, Hoda Keshmiri Neghab, Motahareh Rezvan

Registry-linked trialOpen access · greenAbstract readReview
PubMed Full text at PMC
In one paragraph

Review in Tanaffos, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06795841 (Photobiomodulation Therapy Versus Integrated Myofascial Release Therapy Techniques In Patients With Moderate COVID 19 Inside Intensive Care Unit, With a Complementary Home Telerehabilitation), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06795841 nacompletednot on this map

Photobiomodulation Therapy Versus Integrated Myofascial Release Therapy Techniques In Patients With Moderate COVID 19 Inside Intensive Care Unit, With a Complementary Home Telerehabilitation

TypeinterventionalSponsorBeni-Suef UniversityRan2020 to 2020Enrolled102ConditionsCOVID 19 DiseaseArmsPhotobiomodulation, Myofascial release therapy, traditional chest physiotherapy, telerehabilitation
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. The virucidal potential effects of violet-blue light on influenza D virus.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Seyedeh Sara AzadehDepartment of Medical Laser, Medical Laser Research Center, Yara Institute, ACECR, Tehran, Iran.
Gholamreza Esmaeeli DjavidDepartment of Medical Laser, Medical Laser Research Center, Yara Institute, ACECR, Tehran, Iran.
Sima NobariResearch Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Hoda Keshmiri NeghabDepartment of Medical Laser, Medical Laser Research Center, Yara Institute, ACECR, Tehran, Iran.
Motahareh RezvanDepartment of Medical Laser, Medical Laser Research Center, Yara Institute, ACECR, Tehran, Iran.
Hamedan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pandemic outbreak of Coronavirus disease 2019 (COVID-19) which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2), is a new viral infection in all countries around the world. An increase in inflammatory cytokines, fever, dry cough, and pneumonia are the main symptoms of COVID-19. A shared of growing clinical evidence confirmed that cytokine storm correlates with COVID-19 severity which is also a crucial cause of death from COVID-19. The success of anti-inflammatory therapies in the recovery process of COVID-19 patients has been well established. Over the years, phototherapy (PhT) has been identified as a promising non-invasive treatment approach for inflammatory conditions. New evidence suggests that PhT as an anti-inflammatory therapy may be effective in treating acute respiratory distress syndrome (ARDS) and COVID-19. This review aims to a comprehensive overview of the direct and indirect effects of anti-inflammatory mechanisms of PhT in ARDS and COVID-19 patients.

Indexed as

Anti-inflammatoryCOVID-19PhotobiomodulationPhotodynamic therapyUltraviolet therapy

Identifiers

PMID38638386
PMCPMC11022193
OpenAlexW4394962510

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.